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Abstract
Background: Blood platelets undergo a carefully regulated change in shape to serve as the primary mediators of
hemostasis and thrombosis. These processes manifest through platelet spreading and aggregation and are
dependent on platelet actin cytoskeletal changes orchestrated by the Rho GTPase family member Rac1. To
elucidate how Rac1 is regulated in platelets, we captured Rac1-interacting proteins from platelets and identified
Rac1-associated proteins by mass spectrometry.
Findings: Here, we demonstrate that Rac1 captures the Rac guanine nucleotide exchange factor P-Rex1 from
platelet lysates. Western blotting experiments confirmed that P-Rex1 is expressed in platelets and associated with
Rac1. To investigate the functional role of platelet P-Rex1, platelets from P-Rex1
-/--deficient mice were treated with
platelet agonists or exposed to platelet activating surfaces of fibrinogen, collagen and thrombin. Platelets from P-
Rex1
-/- mice responded to platelet agonists and activating surfaces similarly to wild type platelets.
Conclusions: These findings suggest that P-Rex1 is not required for Rac1-mediated platelet activation and that the
GEF activities of P-Rex1 may be more specific to GPCR chemokine receptor mediated processes in immune cells
and tumor cells.
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Findings
Upon exposure to agonist signals of vascular injury, pla-
telets spread out on sites of vessel damage to form
thrombotic plugs [1,2]. During this process, platelets
undergo an ordered series of shape changes that are
determined by a spatial reorganization of the actin
cytoskeleton [3]. These geometric changes that occur in
the activated platelet are regulated by many of the same
proteins that confer motility and regulate the cytoskele-
ton in nucleated cells, namely the Rho family of
GTPases, including Cdc42, Rac1, and RhoA [4]. Accord-
ingly, conditional knock-out mice models deficient in
Rac1 do not undergo normal platelet spreading or
aggregation and form a weak primary platelet plug over
a site of vascular injury [5]. Similarly, constitutive
deactivation of RhoA in platelets results in reduced pla-
telet adhesion and an unstable thrombus [6].
Rho family GTPases are regulated in a cyclical manner
by different classes of Rho-GTPase binding proteins.
When platelets are stimulated to form a plug over the
site of vascular injury, guanine nucleotide exchange fac-
tors (GEFs) such as Vav1 bind the Rac1 GTPase in its
GDP conjugated form and catalyze a nucleotide
exchange reaction to form Rac1-GTP [7]. Rac1-GTP is
then able to bind downstream effecter proteins that reg-
ulate cytoskeletal proteins to form actin and myosin fila-
ments. While Vav1 is known to control Rac1-based
thrombotic activities in platelets, other well-established
Rac1 GEFs have not been explored in regulating
thrombosis.
To better understand how Rac1 is activated in plate-
lets, we captured Rac1-associated proteins from platelet
lysates and identified potential Rac1 regulatory proteins
from thrombin-stimulated platelets by mass spectrome-
try. Platelets were purified from platelet rich plasma
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adjusted to a concentration of 1 × 10
9/ml. Lysates were
prepared from resting platelets or platelets activated
with 5 U/ml thrombin for 5 minutes. Immobilized
Rac1-GST or GDP and GTP-loaded Rac1-GST were
added to precleared lysates and incubated for 1 hour at
4°C. Rac1-associated proteins were eluted into Laemelli
sample buffer and separated by PAGE. Silver-stained gel
slabs from thrombin stimulated Rac1-GST eluates corre-
sponding to 70 - 250 kD (Figure 1A, lanes 6, 7 and 8)
were each separately digested with trypsin and resulting
peptide fragments were analyzed with a ThermoFinne-
gan LTQ quadrupole linear ion trap spectophotometer
fitted with an Ion Max nanospray source. Mass spectra
were analyzed with Sequest software (Proteomics Shared
Research Center, OHSU) and sequences were compared
using Scaffold 2.1 software. Mass spectrometry capture
experiments revealed that GTP-loaded Rac1-GST cap-
tured the Rac1 GEF P-Rex1 from thrombin-stimulated
platelet lysates. Nine unique trypsin-digested P-Rex1
peptides were recovered (Table 1), representing 6%
sequence coverage (103/1659 amino acids). Platelet
lysates and Rac1-GST eluates were western blotted for
the presence of P-Rex1 (Figure 1B), confirming that P-
Rex1 is abundant in human platelets (input) and asso-
ciated with Rac1 in vitro.
P-Rex1 functions as a specific Rac1 and Rac2 activator
in neutrophils [9,10], endothelial cells [11] and breast
cancer cells [12]. Intriguingly, the guanine nucleotide
exchange activity of P-Rex1 is known to be regulated by
both Gb/g and phosphoinositol-3,4,5 phosphate (PIP3)
[9,13,14], suggesting that P-Rex1 could be involved in
regulating G-protein coupled receptor (GPCR) pathways
triggered by platelet agonists such as thrombin [15,16]
and ADP [17]. Interestingly, we found that a ternary
complex consisting of P-Rex1, Rac1-GTP and Gb/g
occurs only in the thrombin-activated platelets (data not
shown). P-Rex1 activity is also regulated through mTOR
signaling [18], and recent work has described a role for
mTOR in the activation of platelet Rac1 through an
undetermined mechanism [19]. Accordingly, we
hypothesized that P-Rex1 may function as an important
Rac activator in response to stimulation of PARs and
other platelet GPCRs.
Thrombin markedly upregulated Rac1 activity in pla-
telets from wild type mice as determined by capture of
activated Rac1-GTP from quiescent versus stimulated
platelet lysates [5] (Figure 1C). Protein capture and wes-
tern blotting analyses confirmed that P-Rex1 is
expressed in mouse platelets and capable of associating
with GTP-loaded Rac1 (Figure 1D). To determine if P-
Rex1 has a role in GPCR-triggered and Rac1-dependent
platelet lamellipodia formation and surface spreading,
we isolated platelets from P-Rex1-deficeint mice [10]
and exposed them to platelet activating surfaces.
Washed mouse platelets (2 × 10
7/ml) from wild type (P-
Rex1
+/+)o rP-Rex1
-/- mice were placed on 100 μg/ml
fibrinogen-coated coverglass in the presence of vehicle,
Figure 1 Identification of P-Rex1 as a Rac1-associated protein
in platelets. Lysates from quiescent or thrombin stimulated
platelets were incubated with glutathione agarose conjugated to
GST-tagged Rac1, GDP-loaded Rac1, GTP-loaded Rac1 or GST alone.
(A) Captured proteins were eluted into sample buffer and resolved
by SDS-PAGE followed by silver staining. (B) Captured protein
eluates and whole platelet lysates (input, middle panel) were
probed for the presence of P-Rex1 by western blot (WB) with P-
Rex1 antisera sc-85805 (Santa Cruz) as previously described [24,25].
Total Rac1-GST and GST protein inputs for capture experiments are
shown by Coomassie stain. (C) Platelets from wild type mice (5 ×
10
8/ml) were treated with 1 U/ml of thrombin for 5 minutes and
analyzed for Rac1 activation as previously described [5]. (D)
Thrombin-stimulated mouse platelets were lysed in MPER buffer as
previously described [19] and incubated with glutathione agarose
conjugated to GTP-loaded Rac1-GST or GST alone for 1 hour at 4°C.
Eluates were probed for mouse P-Rex1 capture by western blot
(WB). Total P-Rex1 from mouse platelet lysates is shown as input
(10% of total P-Rex1). Total Rac1-GST and GST protein inputs for
capture experiments are shown by Coomassie stain.
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nists thrombin (1 U/ml) or ADP (10 μM) for 45 minutes
at 37°C and were examined using differential interfer-
ence contrast (DIC) microscopy. Platelets from wild
type and P-Rex1
-/- mice attached to fibrinogen surfaces
at the same level (Figure 2A). The addition of the plate-
let GPCR agonists thrombin or ADP triggered platelet
spreading on a surface of fibrinogen to a similar extent
in both wild type and P-Rex1
-/- platelets (Figure 2A).
Deletion of P-Rex1 similarly had no effect on the
spreading of platelets on a surface of fibrillar collagen
(Figure 2B) or thrombin (Figure 2C).
Table 1 Recovered P-Rex1 peptides
Peptide (n) Sequence
1 EIDQDAYLQLFTK
2 LVDWLLAQGDCQTR
3 FLQSAFLHR
4 NQLLLALLK
5 GSLAEVAGLQVGR
6 TTDIPLEGYLLSPIQR
7 IACYQEFAAQLK
8 TTDIPLEGYLLSPIQR
9 LCVLNEIGTER
Figure 2 Substrate surface spreading of P-Rex1-/- platelets. Washed mouse platelets from wild type (P-Rex1
+/+)o rP-Rex1
-/- mice were placed
on 100 μg/ml fibrinogen-coated (A), 100 μg/ml fibrillar collagen-coated (B) or 50 μg/ml thrombin-coated (C) coverslips in the presence of
vehicle, 2 U/ml apyrase (+apy), apyrase and 1 U/ml thrombin (+apy/+thr) or 10 μM ADP for 45 min at 37°C and imaged by DIC microscopy. The
individual surface areas of 300 P-Rex1
+/+ (black line) and 300 P-Rex1
-/- (grey line) platelets were quantified using Image J software and plotted as
a frequency distribution. DIC images and platelet surface area histograms are representative of > 3 experiments. Scale bar = 10 μm.
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acts with P-Rex1 from platelets, however, the GEF activ-
ity of P-Rex1 is not likely essential to PAR and P2Y
GPCR- and Rac1-mediated platelet lamellipodia forma-
tion and spreading. These results suggest that the activ-
ities of P-Rex1 may perhaps be more specific to GPCR
chemokine receptor (CXCR)-mediated events in
immune cells [10] and tumor cells [12,20-22]. While P-
Rex1 alone does not appear to have a requisite role in
activating Rac1 in platelets, recent studies suggest that
P-Rex1 can work together with Vav1 to contribute to
Rac1 activation [23]. Whether or not P-Rex1 has a sec-
ondary role in regulating platelet Rac1 activation and
the potential context of such an accessorizing function
of P-Rex1 in platelets remains to be determined.
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